Position in CLDX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$109,211
+$30,800 QoQ
Shares Held
2,935
+18.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#187
of 253 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantbot Technologies LP holds $29,328,891 across 118 Biotechnology names. CLDX ranks #53 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
80,193 | $4,496,421 | |
| 2 | TECH |
BIO-TECHNE Corp
|
52,802 | $3,730,461 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
5,724 | $1,071,990 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
17,880 | $975,175 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,460 | $910,368 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,831 | $882,834 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
6,302 | $836,464 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
|
8,884 | $788,721 |
All Filings in CLDX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,211 | 2,935 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $78,411 | 2,472 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,965 | 146 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $63,174 | 2,442 | Shares | Sole | 2025-11-12 | |
| 2024-09-30 | $3,229 | 95 | Shares | Sole | 2024-11-13 | |
| 2022-03-31 | $13,624 | 400 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $38,640 | 1,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,798 | 200 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $26,752 | 800 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||